Sleep Medicine
From the Journals
Schizophrenia meds a key contributor to cognitive impairment
The investigators found that 63% of participants had an anticholinergic cognitive burden score of at least 3, which is "striking."
Supplements
Sleep Medicine A Special Report
From the Journals
Long-term use of prescription sleep meds unsupported by new research
Study authors compare sleep disturbance data for users and nonusers of sleep medications.
Conference Coverage
Once-nightly sodium oxybate agent effective in narcolepsy
All three doses of the novel agent were associated with significant improvements in sleep quality, refreshing nature of sleep, sleep paralysis,...
Conference Coverage
Insomnia? Referral, drugs not usually needed
‘Restricted sleep’ is a good place to start, says expert.
From the Journals
HIV patients show accelerated aging related to altered sleep
“One of the functions of slow-wave sleep appears to be its association with the glymphatic system, which clears [metabolic] waste products and...
From the Journals
‘Beyond a reasonable doubt’: COVID-19 brain health fallout is real, severe
From the Journals
Cannabinoids promising for improving appetite, behavior in dementia
Early evidence suggests that cannabinoids may also be beneficial for pain, sleep, and aggression.
From the Journals
Traumatic brain injury tied to long-term sleep problems
The association with sleep disorders was strongest among those with mild TBI versus a more severe brain injury.
Conference Coverage
Sleep apnea and cognitive impairment are common bedfellows
“People with cognitive impairment should be assessed for sleep apnea if they have difficulty with sleep or if they demonstrate sleep-related...
From the Journals
Study: Central sleep apnea is common in ticagrelor users post ACS
“Whether this particular drug-induced central sleep apnea is consequential” is an open question, says outside expert.